Captor Therapeutics Nominates the Molecular Glue CPT-6281 as Drug Candidate to Enter CTA/IND-Enabling Studies for the Treatment of Hepatocellular Carcinoma
WROCŁAW, Poland, Aug. 10, 2022 (GLOBE NEWSWIRE) — Captor Therapeutics S.A. (WSE:CTX), a biopharmaceutical company…
Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community
Columbus Therapist Yvonne Judge Seeks Participants for Doctoral Research on EMDR Therapy and Family Relationships
Saudi Arabia Hit 85% Digital: The Rails Under the Card Are Next
Creative Pass Studio Launches Unlimited Design Monthly Pass, Giving Agencies and Growing Businesses a Senior Creative Team Without Adding Headcount
Stardust Appoints Eamonn McHugh as CEO in Strategic Leadership Transition